Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Details - Outstanding Securities Considered Anti-Dilutive (Details)

v3.24.1.u1
Condensed Consolidated Financial Statements Details - Outstanding Securities Considered Anti-Dilutive (Details) - $ / shares
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Antidilutive Securities Excluded From Computation Of Earnings Per Share    
Antidilutive securities excluded from computation of net loss per share (in shares) 6,506,000 6,557,000
Performance Stock Unit Awards    
Antidilutive Securities Excluded From Computation Of Earnings Per Share    
Shares issuable based on market price 0  
Common Stock    
Antidilutive Securities Excluded From Computation Of Earnings Per Share    
Stock price (in dollars per share) $ 24.05  
Convertible preferred stock    
Antidilutive Securities Excluded From Computation Of Earnings Per Share    
Antidilutive securities excluded from computation of net loss per share (in shares) 5,003,000 5,003,000
Employee Stock Option    
Antidilutive Securities Excluded From Computation Of Earnings Per Share    
Antidilutive securities excluded from computation of net loss per share (in shares) 1,372,000 1,548,000
Warrants for common stock    
Antidilutive Securities Excluded From Computation Of Earnings Per Share    
Antidilutive securities excluded from computation of net loss per share (in shares) 131,000 6,000